95 related articles for article (PubMed ID: 12461005)
1. In vitro transfer of clarithromycin and amoxicillin across the epithelial barrier: effect of Helicobacter pylori.
Matysiak-Budnik T; Heyman M; Candalh C; Lethuaire D; Mégraud F
J Antimicrob Chemother; 2002 Dec; 50(6):865-72. PubMed ID: 12461005
[TBL] [Abstract][Full Text] [Related]
2. In-vitro transfer of nitazoxanide across the intestinal epithelial barrier.
Matysiak-Budnik T; Mégraud F; Heyman M
J Pharm Pharmacol; 2002 Oct; 54(10):1413-7. PubMed ID: 12396305
[TBL] [Abstract][Full Text] [Related]
3. Helicobacter pylori alters exogenous antigen absorption and processing in a digestive tract epithelial cell line model.
Matysiak-Budnik T; Terpend K; Alain S; Sanson le Pors MJ; Desjeux JF; Mégraud F; Heyman M
Infect Immun; 1998 Dec; 66(12):5785-91. PubMed ID: 9826355
[TBL] [Abstract][Full Text] [Related]
4. Can lansoprazole, amoxicillin, and clarithromycin combination still be used as a first-line therapy for eradication of helicobacter pylori?
Güliter S; Keleş H; Ozkurt ZN; Cengiz DU; Kolukisa E
Turk J Gastroenterol; 2005 Mar; 16(1):29-33. PubMed ID: 16252185
[TBL] [Abstract][Full Text] [Related]
5. Impact of acid secretion, gastritis, and mucus thickness on gastric transfer of antibiotics in rats.
Sherwood PV; Wibawa JI; Atherton JC; Jordan N; Jenkins D; Barrett DA; Shaw PN; Spiller RC
Gut; 2002 Oct; 51(4):490-5. PubMed ID: 12235069
[TBL] [Abstract][Full Text] [Related]
6. Helicobacter pylori and gastric or duodenal ulcer.
Prescrire Int; 2016 Jan; 25(167):18-23. PubMed ID: 26942258
[TBL] [Abstract][Full Text] [Related]
7. New pharmacokinetic in vitro model for studies of antibiotic activity against intracellular microorganisms.
Hultén K; Rigo R; Gustafsson I; Engstrand L
Antimicrob Agents Chemother; 1996 Dec; 40(12):2727-31. PubMed ID: 9124830
[TBL] [Abstract][Full Text] [Related]
8. Reverse sequential therapy achieves a similar eradication rate as standard sequential therapy for Helicobacter pylori eradication: a randomized controlled trial.
Tsay FW; Wu DC; Kao SS; Tsai TJ; Lai KH; Cheng JS; Chan HH; Wang HM; Tsai WL; Tseng HH; Peng NJ; Hsu PI
Helicobacter; 2015 Feb; 20(1):71-7. PubMed ID: 25495272
[TBL] [Abstract][Full Text] [Related]
9. One-week triple regime therapy consisting of pantoprazole, amoxicillin and clarithromycin for cure of Helicobacter pylori-associated upper gastrointestinal diseases.
Dajani AI; Awad S; Ukabam S; Nounou MA; Abdul Rasheed Z; Gautam S; Abdul Aal G; Nayal S
Digestion; 1999; 60(3):298-304. PubMed ID: 10343146
[TBL] [Abstract][Full Text] [Related]
10. Emerging antimicrobial resistance pattern of Helicobacter pylori in central Gujarat.
Pandya HB; Agravat HH; Patel JS; Sodagar NR
Indian J Med Microbiol; 2014; 32(4):408-13. PubMed ID: 25297026
[TBL] [Abstract][Full Text] [Related]
11. Comparison of omeprazole, metronidazole and clarithromycin with omeprazole/amoxicillin dual-therapy for the cure of Helicobacter pylori infection.
Miehlke S; Meining A; Lehn N; Höchter W; Weingart J; Simon T; Krämer W; Klann H; Bolle K; Sommer A; Stolte M; Bayerdörffer E
Digestion; 1998; 59(6):646-50. PubMed ID: 9813387
[TBL] [Abstract][Full Text] [Related]
12. Effect of plaunotol in combination with clarithromycin or amoxicillin on Helicobacter pylori in vitro and in vivo.
Koga T; Inoue H; Ishii C; Okazaki Y; Domon H; Utsui Y
J Antimicrob Chemother; 2002 Jul; 50(1):133-6. PubMed ID: 12096020
[TBL] [Abstract][Full Text] [Related]
13. High-dose omeprazole plus amoxicillin or clarithromycin cures Helicobacter pylori infection in duodenal ulcer disease.
Labenz J; Stolte M; Domian C; Bertrams J; Börsch G
Digestion; 1995; 56(1):14-20. PubMed ID: 7895926
[TBL] [Abstract][Full Text] [Related]
14. Triple versus dual therapy for eradicating Helicobacter pylori and preventing ulcer recurrence: a randomized, double-blind, multicenter study of lansoprazole, clarithromycin, and/or amoxicillin in different dosing regimens.
Schwartz H; Krause R; Sahba B; Haber M; Weissfeld A; Rose P; Siepman N; Freston J
Am J Gastroenterol; 1998 Apr; 93(4):584-90. PubMed ID: 9576452
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic drug interaction and safety after coadministration of clarithromycin, amoxicillin, and ilaprazole: a randomised, open-label, one-way crossover, two parallel sequences study.
Jin BH; Yoo BW; Park J; Kim JH; Lee JY; Shin JS; Park MS
Eur J Clin Pharmacol; 2018 Sep; 74(9):1149-1157. PubMed ID: 29846770
[TBL] [Abstract][Full Text] [Related]
16. Reduced symptoms and need for antisecretory therapy in veterans 3 years after Helicobacter pylori eradication with ranitidine bismuth citrate/amoxicillin/clarithromycin.
Sontag SJ; O'Connell S; Schnell T; Chejfec G; Seidel J; Sonnenberg A
Am J Gastroenterol; 2001 May; 96(5):1390-5. PubMed ID: 11374672
[TBL] [Abstract][Full Text] [Related]
17. [Antimicrobial susceptibility of Helicobacter pylori with chronic gastritis].
Figueroa M; Cortés A; Pazos Á; Bravo LE
Biomedica; 2012; 32(1):32-42. PubMed ID: 23235785
[TBL] [Abstract][Full Text] [Related]
18. Recent success of pantoprazole -or lansoprazole- based clarithromycin plus amoxicillin treatment in the eradication of Helicobacter pylori.
Uygun A; Kadayifçi A; Yeşilova Z; Savaş MC; Ateş Y; Karslioğlu Y; Ciğerim M; Bağci S; Dağalp K
Turk J Gastroenterol; 2004 Dec; 15(4):219-24. PubMed ID: 16249974
[TBL] [Abstract][Full Text] [Related]
19. Helicobacter pylori infection in hemodialysis patients: susceptibility to amoxicillin and clarithromycin.
Aydemir S; Boyacioglu S; Gur G; Demirbilek M; Can FK; Korkmaz M; Yilmaz U
World J Gastroenterol; 2005 Feb; 11(6):842-5. PubMed ID: 15682477
[TBL] [Abstract][Full Text] [Related]
20. [Preliminary study on in-vitro induction of antibiotic resistance in Helicobacter pylori strains isolated from children].
Yan WH; Chen J; Hu HJ; Yu JD; Huang XL; Li ZY
Zhonghua Er Ke Za Zhi; 2007 Sep; 45(9):708-11. PubMed ID: 18021568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
